385 related articles for article (PubMed ID: 32857360)
1. Targeted Therapy for Chronıc Spontaneous Urtıcarıa: Ratıonale and Recent Progress.
Giménez-Arnau AM; Salman A
Drugs; 2020 Nov; 80(16):1617-1634. PubMed ID: 32857360
[TBL] [Abstract][Full Text] [Related]
2. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease.
Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A
Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278
[TBL] [Abstract][Full Text] [Related]
3. New treatments for chronic urticaria.
Kolkhir P; Altrichter S; Munoz M; Hawro T; Maurer M
Ann Allergy Asthma Immunol; 2020 Jan; 124(1):2-12. PubMed ID: 31446134
[TBL] [Abstract][Full Text] [Related]
4. New biologics in the treatment of urticaria.
Kocatürk E; Zuberbier T
Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):425-431. PubMed ID: 30015639
[TBL] [Abstract][Full Text] [Related]
5. Hematologic parameters as biomarkers for antihistamine and omalizumab resistance in chronic spontaneous urticaria.
Magen E; Waitman DA; Kahan NR
Allergy Asthma Proc; 2021 Jan; 42(1):e17-e24. PubMed ID: 33404397
[No Abstract] [Full Text] [Related]
6. Omalizumab in the Treatment of Chronic Urticaria: The Effect of Drug Co-Administration and Co-Morbidities.
Tagka A; Lambrou GI; Nicolaidou E; Nakou E; Makris M; Stratigos A; Katsarou A
Antiinflamm Antiallergy Agents Med Chem; 2021; 20(1):39-50. PubMed ID: 32013838
[TBL] [Abstract][Full Text] [Related]
7. Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies.
Orzan OA; Popa LG; Mihai MM; Cojocaru A; Giurcăneanu C; Dorobanțu AM
Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744079
[TBL] [Abstract][Full Text] [Related]
8. A retrospective analysis omalizumab treatment patterns in patients with chronic spontaneous urticaria: a real-world study in Belgium.
Lapeere H; Baeck M; Stockman A; Sabato V; Grosber M; Moutschen M; Lambert J; Vandebuerie L; de Montjoye L; Rabijns H; Allewaert K; Schrijvers R
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):127-134. PubMed ID: 31099916
[TBL] [Abstract][Full Text] [Related]
9. Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy.
Liao SL; Yu M; Zhao ZT; Maurer M
Front Immunol; 2021; 12():652973. PubMed ID: 33796115
[TBL] [Abstract][Full Text] [Related]
10. Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.
Kaplan A; Lebwohl M; Giménez-Arnau AM; Hide M; Armstrong AW; Maurer M
Allergy; 2023 Feb; 78(2):389-401. PubMed ID: 36448493
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence.
Metz M; Vadasz Z; Kocatürk E; Giménez-Arnau AM
Clin Rev Allergy Immunol; 2020 Aug; 59(1):38-45. PubMed ID: 32418171
[TBL] [Abstract][Full Text] [Related]
12. Current and emerging pharmacotherapy for chronic spontaneous Urticaria: a focus on non-biological therapeutics.
Hon KL; Li JTS; Leung AKC; Lee VWY
Expert Opin Pharmacother; 2021 Mar; 22(4):497-509. PubMed ID: 32990110
[TBL] [Abstract][Full Text] [Related]
13. Case Report: Refractory Chronic Spontaneous Urticaria Treated With Omalizumab in an Adolescent With Crohn's Disease.
Barni S; Giovannini M; Liccioli G; Sarti L; Gissi A; Lionetti P; Mori F
Front Immunol; 2021; 12():635069. PubMed ID: 33737936
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-33, endothelin-1, and inflammatory parameters in chronic spontaneous urticaria.
Kulumbegov B; Chikovani T; Gotua M; Kikodze N; Magen E
Allergy Asthma Proc; 2023 Nov; 44(6):429-435. PubMed ID: 37919851
[No Abstract] [Full Text] [Related]
15. Differences between adult and pediatric chronic spontaneous urticaria from a cohort of 751 patients: Clinical features, associated conditions and indicators of treatment response.
Özçeker D; Can PK; Terzi Ö; Ornek SA; Değirmentepe EN; Kızıltac K; Sarac E; Kocatürk E
Pediatr Allergy Immunol; 2023 Feb; 34(2):e13925. PubMed ID: 36825740
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17 is a potential player and treatment target in severe chronic spontaneous urticaria.
Sabag DA; Matanes L; Bejar J; Sheffer H; Barzilai A; Church MK; Toubi E; Maurer M; Vadasz Z
Clin Exp Allergy; 2020 Jul; 50(7):799-804. PubMed ID: 32412136
[TBL] [Abstract][Full Text] [Related]
17. Dramatic improvement with colchicine in antihistamine- and omalizumab-resistant chronic spontaneous urticaria.
Abe N; Bohgaki M; Kasahara H
Clin Exp Dermatol; 2022 Dec; 47(12):2308-2310. PubMed ID: 36052842
[TBL] [Abstract][Full Text] [Related]
18. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: A multi-center retrospective case series.
Ari A; Levy Y; Segal N; Maoz-Segal R; Benor S; Broides A; Horev A; Epstein-Rigbi N; Agmon-Levin N; Marcus N
Pediatr Dermatol; 2020 Nov; 37(6):1051-1054. PubMed ID: 32951239
[TBL] [Abstract][Full Text] [Related]
20. How to Treat Patients with Chronic Spontaneous Urticaria with Omalizumab: Questions and Answers.
Türk M; Carneiro-Leão L; Kolkhir P; Bonnekoh H; Buttgereit T; Maurer M
J Allergy Clin Immunol Pract; 2020 Jan; 8(1):113-124. PubMed ID: 31374358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
